Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2007 1
2009 1
2010 5
2012 2
2013 2
2014 3
2016 2
2017 2
2018 3
2019 1
2020 3
2021 1
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Assessing survival outcomes and complication profiles following surgical excision and radiotherapy as interventions for skull base chordoma: a systematic review of operative margins and surgical approaches.
Brown NJ, Gendreau J, Kuo CC, Nguyen O, Yang C, Catapano JS, Lawton MT. Brown NJ, et al. J Neurooncol. 2023 Oct;165(1):41-51. doi: 10.1007/s11060-023-04477-2. Epub 2023 Oct 25. J Neurooncol. 2023. PMID: 37880419 Review.
METHODS: Accordingly, we performed a systematic review in order to profile surgical and survival outcomes for skull base chordoma. Fixed and random-effect meta-analyses were performed for categorical variables including GTR, STR, 5-year OS, 10-year OS, …
METHODS: Accordingly, we performed a systematic review in order to profile surgical and survival outcomes for skull base ch …
Long-term outcomes of skull base chordoma treated with high-dose carbon-ion radiotherapy.
Koto M, Ikawa H, Kaneko T, Hagiwara Y, Hayashi K, Tsuji H. Koto M, et al. Head Neck. 2020 Sep;42(9):2607-2613. doi: 10.1002/hed.26307. Epub 2020 May 30. Head Neck. 2020. PMID: 32472716 Free PMC article.
BACKGROUND: We evaluated the long-term efficacy and safety of carbon-ion radiotherapy (C-ion RT) for skull base chordoma, a rare neoplasm. METHODS: Thirty-four patients with skull base chordoma who were treated with C-ion RT were prospect …
BACKGROUND: We evaluated the long-term efficacy and safety of carbon-ion radiotherapy (C-ion RT) for skull base chordoma …
Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma.
De Leo AN, Holtzman AL, Ho MW, Morris CG, Rutenberg MS, Rotondo RL, Bates JE, Indelicato DJ, Rao D, Asa Hasan M, Mendenhall WM. De Leo AN, et al. Radiother Oncol. 2021 May;158:125-130. doi: 10.1016/j.radonc.2021.02.012. Epub 2021 Feb 19. Radiother Oncol. 2021. PMID: 33610625
We report the incidence of vision loss following high-dose conformal proton-based radiotherapy. MATERIALS AND METHODS: We reviewed patients with skull-base chordoma or chondrosarcoma treated with proton-based therapy between 2007 and 2018. ...CONCLUSIONS: Des …
We report the incidence of vision loss following high-dose conformal proton-based radiotherapy. MATERIALS AND METHODS: We reviewed patients …
Iatrogenic seeding of skull base chordoma following endoscopic endonasal surgery.
Fernandes Cabral DT, Zenonos GA, Fernandez-Miranda JC, Wang EW, Gardner PA. Fernandes Cabral DT, et al. J Neurosurg. 2018 Oct;129(4):947-953. doi: 10.3171/2017.6.JNS17111. Epub 2017 Dec 22. J Neurosurg. 2018. PMID: 29271711
METHODS: The authors retrospectively reviewed their experience with EES for clival chordoma, focusing on cases with iatrogenic seeding. The clinical, radiographic, pathological, and molecular characterization data were reviewed. ...
METHODS: The authors retrospectively reviewed their experience with EES for clival chordoma, focusing on cases with iatrogenic seeding. The …
The incidence of brainstem toxicity following high-dose conformal proton therapy for adult skull-base malignancies.
Holtzman AL, Rutenberg MS, De Leo AN, Rao D, Patel J, Morris CG, Indelicato DJ, Mendenhall WM. Holtzman AL, et al. Acta Oncol. 2022 Aug;61(8):1026-1031. doi: 10.1080/0284186X.2022.2101900. Epub 2022 Jul 27. Acta Oncol. 2022. PMID: 35897132
MATERIAL AND METHODS: We performed a single-institution review of patients with skull-base chordoma or chondrosarcoma who were treated with proton therapy between February 2007 and January 2020 on a prospective outcomes-tracking protocol. ...There was one gra …
MATERIAL AND METHODS: We performed a single-institution review of patients with skull-base chordoma or chondrosarcoma w …
On the cost-effectiveness of Carbon ion radiation therapy for skull base chordoma.
Jäkel O, Land B, Combs SE, Schulz-Ertner D, Debus J. Jäkel O, et al. Radiother Oncol. 2007 May;83(2):133-8. doi: 10.1016/j.radonc.2007.03.010. Epub 2007 May 8. Radiother Oncol. 2007. PMID: 17490770 Review.
AIM: The cost-effectiveness of Carbon ion radiotherapy (RT) for patients with skull base chordoma is analyzed. MATERIALS AND METHODS: Primary treatment costs and costs for recurrent tumors are estimated. ...Using various scenarios for the local control rate a …
AIM: The cost-effectiveness of Carbon ion radiotherapy (RT) for patients with skull base chordoma is analyzed. MATERIAL …
Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy.
Basler L, Poel R, Schröder C, Bolsi A, Lomax A, Tanadini-Lang S, Guckenberger M, Weber DC. Basler L, et al. Radiat Oncol. 2020 Nov 16;15(1):266. doi: 10.1186/s13014-020-01711-3. Radiat Oncol. 2020. PMID: 33198810 Free PMC article.
BACKGROUND: Despite combined modality treatment involving surgery and radiotherapy, a relevant proportion of skull-base chordoma and chondrosarcoma patients develop a local recurrence (LR). ...CONCLUSION: This study identified DVH parameters, which are associ …
BACKGROUND: Despite combined modality treatment involving surgery and radiotherapy, a relevant proportion of skull-base cho …
Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience.
Mattke M, Ohlinger M, Bougatf N, Harrabi S, Wolf R, Seidensaal K, Welzel T, Röder F, Gerum S, Ellerbrock M, Jäkel O, Haberer T, Herfarth K, Uhl M, Debus J. Mattke M, et al. Strahlenther Onkol. 2023 Feb;199(2):160-168. doi: 10.1007/s00066-022-02002-4. Epub 2022 Sep 23. Strahlenther Onkol. 2023. PMID: 36149438 Free PMC article.
Biological Dose Optimization for Particle Arc Therapy Using Helium and Carbon Ions.
Mein S, Tessonnier T, Kopp B, Schömers C, Harrabi S, Abdollahi A, Debus J, Haberer T, Mairani A. Mein S, et al. Int J Radiat Oncol Biol Phys. 2022 Oct 1;114(2):334-348. doi: 10.1016/j.ijrobp.2022.04.025. Epub 2022 Apr 29. Int J Radiat Oncol Biol Phys. 2022. PMID: 35490991
Three patient cases previously treated at the Heidelberg Ion-beam Therapy Center (HIT) were selected for evaluation of conventional versus arc delivery for the two clinical particle beams (helium [(4)He] and carbon [(12)C] ions): glioblastoma, prostate adenocarcinoma, and …
Three patient cases previously treated at the Heidelberg Ion-beam Therapy Center (HIT) were selected for evaluation of conventional versus a …
32 results